Instil Bio Inc (TIL) - News Archive

In the dynamic landscape of oncological treatments, the recent developments by Instil Bio Inc. in the realm of immune oncology have sparked interest within the scientific community. The company’s announcement of the pos...

In a significant step forward in oncology, Instil Bio, Inc. (Nasdaq: TIL) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX:1541) have unveiled an ambitious global registrational strategy for their innovative PD-L...

In an industry-defining collaboration, Instil Bio, Inc. (Nasdaq: TIL, Instil) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, ImmuneOnco) have announced a landmark agreement focusing on innovative...

In exciting news in the field of biopharmaceuticals, Instil Bio, Inc. recently released a strategic update, outlining their path forward in developing revolutionary tumor infiltrating lymphocyte (TIL) therapies for pati...